Yutaka Yamamoto, Mituhisa Nishimoto, Yasunori Akashi, Keisuke Kiba, Takafumi Minami, Masahiro Nozawa, Kazuhiro Yoshimura, Akihide Hirayama, Hirotsugu Uemura, Kazutoshi Fujita. Impact of Novel Agents on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer. Anticancer research. 2024. 44. 7. 3155-3161
Taigo Kato, Yuzo Nakano, Fumiya Hongo, Hidenori Katano, Tomoaki Miyagawa, Kosuke Ueda, Haruhito Azuma, Masahiro Nozawa, Nobuyuki Hinata, Junichi Hori, et al. Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART). International journal of urology : official journal of the Japanese Urological Association. 2024. 31. 3. 265-272
Mitsuhisa Nishimoto, Kazutoshi Fujita, Aritoshi Ri, Saizo Fujimoto, Yasuo Oguma, Shingo Toyoda, Mamoru Hashimoto, Takashi Kikuchi, Shogo Adomi, Yoshitaka Saito, et al. Gleason Pattern 5 May Be a Prognostic Factor in Radium-223 Treatment. Cancer diagnosis & prognosis. 2024. 4. 4. 441-446